Tracked deals
3
3 tracked deals across 2023-2026.
Operating Company
Healthcare
Viome
Bellevue, Washington, United States
AI-driven precision prevention and personalized healthcare company providing at-home molecular diagnostics that analyze the microbiome and human gene expression (mRNA) to generate actionable nutrition and supplement recommendations, and advancing prediction, early diagnostics, prognostics, and precision therapeutics using host/microbial biomarkers.
- Focus Areas
- Longevity / preventative healthcare, At-home microbiome testing, Human gene expression (mRNA) testing
- Website
- viomelifesciences.com
Recent pace
2
2 tracked deals announced in the last 12 months.
Deal mix
Buyout
3 buyout
Viome Acquisition Volume by Year
Last 2 years
Actual
Full-year estimate
Supporting Data
Recent Transactions
-
October 9, 2026
- Buyer
- Viome
- Target
- Sōlaria Biō
- Industry
- Healthcare Services
- Location
- United States
- Type
- Buyout
Viome acquired Sōlaria Biō, a clinically validated synbiotics and medical foods company, to expand its personalized health platform into condition-specific interventions. The deal brings Sōlaria’s microbial discovery platform, biobank, machine-learning capabilities, and products—most notably its standalone synbiotic medical food Bōndia—into Viome’s portfolio.
-
August 14, 2026
- Buyer
- Viome Life Sciences
- Target
- Circulate Health
- Industry
- Healthcare Services
- Location
- Washington, United States
- Type
- Buyout
Viome Life Sciences acquired Circulate Health to combine Viome’s molecular diagnostics and precision nutrition platform with Circulate’s physician-guided therapeutic plasma exchange (TPE) delivered through a nationwide network of clinical partners. The deal expands the combined platform to more than 200 clinics and supports Viome’s strategy of linking diagnostics to personalized interventions and tracking outcomes over time.
-
- Buyer
- Viome Life Sciences
- Target
- Naring Health, DiscernDX, Foodome
- Industry
- Healthcare Services
- Location
- California, United States
- Type
- Buyout
Viome Life Sciences has acquired digital health startup Naring Health, including its subsidiaries DiscernDX and Foodome, to expand its capabilities in multi-omics, diagnostics and precision nutrition. The deal brings together microbiome analysis, proteomics and foodomics capabilities to enhance Viome's personalized nutrition and early disease detection offerings.
Related Acquisition Pages
Selling a company? Get in front of buyers like Viome
Turn tracked acquisition activity into an outreach-ready buyer list.